Skip to main content

Table 3 Complementary analyses: Medical resource utilization and prescribed medications in 2008 in the 3 subgroups identified within the high-ICS-ratio group

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

 

50% ≤ R < 60%

60% ≤ R < 90%

90% ≤ R

p-value

UK

Number of patients

10,929

3,715

2,094

 

Number of respiratory medication prescriptions (mean)

7.5

6.86

3.62

<0.0001

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

12.7%

14.7%

8.9%

<0.0001

Number of prescriptions (mean)

0.2

0.24

0.16

0.0006

Antibiotics (a)

    

Patients with ≥ 1 prescription (%)

41.9%

43.4%

35.5%

<0.0001

Number of prescriptions (mean)

0.8

0.86

0.7

0.0001

Patients with ≥ 1 prescription of LABA-ICS fixed combination (%)

38.9%

56.2%

51%

<0.0001

Number of GP visits (mean)

6.5

7.2

5.9

<0.0001

France (b)

Number of patients

783

597

673

 

Number of respiratory medication prescriptions units (mean)

9.61

11

5.67

<0.0001

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

29.9%

33.3%

28.7%

0.178

Number of units (b) (mean)

0.84

0.82

0.77

0.811

Antibiotics (a)

    

Patients with ≥ 1 prescription (%)

50.7%

55.8%

53.3%

0.17

Number of units (b) (mean)

1.61

1.91

1.52

0.0159

Patients with ≥ 1 prescription of LABA-ICS fixed combination (%)

75.5%

89.9%

82%

<0.0001

Number of GP visits (mean)

5.4

5.8

5.6

0.273

  1. (a)Beta-lactams, cephalosporins (first to third generations), macrolides and fluoroquinolones.
  2. (b)Canisters for inhaled therapy and packages for oral therapy.